These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 27783276

  • 1. Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome.
    Saito T, Iwano M, Matsumoto K, Mitarai T, Yokoyama H, Yorioka N, Nishi S, Yoshimura A, Sato H, Ogahara S, Sasatomi Y, Kataoka Y, Ueda S, Koyama A, Maruyama S, Nangaku M, Imai E, Matsuo S, Tomino Y, Refractory Nephrotic Syndrome Study Group.
    Clin Exp Nephrol; 2017 Dec; 21(6):961-970. PubMed ID: 27783276
    [Abstract] [Full Text] [Related]

  • 2. Significance of combined cyclosporine-prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial.
    Saito T, Iwano M, Matsumoto K, Mitarai T, Yokoyama H, Yorioka N, Nishi S, Yoshimura A, Sato H, Ogahara S, Shuto H, Kataoka Y, Ueda S, Koyama A, Maruyama S, Nangaku M, Imai E, Matsuo S, Tomino Y, Refractory Nephrotic Syndrome Study Group.
    Clin Exp Nephrol; 2014 Oct; 18(5):784-94. PubMed ID: 24363128
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy of mizoribine followed by low-dose prednisone in patients with idiopathic membranous nephropathy and nephrotic-range proteinuria.
    Matsumoto Y, Shimada Y, Nojima Y, Moriki T.
    Ren Fail; 2013 Aug; 35(7):936-41. PubMed ID: 23815417
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Changing mizoribine administration from three divided doses to one single dose induced remission of relapsed membranous nephropathy.
    Nishioka Y, Horita Y, Tadokoro M, Taura K, Suyama N, Miyazaki M, Harada T, Kohno S.
    Nephrol Dial Transplant; 2006 Aug; 21(8):2337-8. PubMed ID: 16547120
    [No Abstract] [Full Text] [Related]

  • 8. High-dose mizoribine treatment for adolescents with systemic lupus erythematosus.
    Nozu K, Iijima K, Kamioka I, Fujita T, Yoshiya K, Tanaka R, Nakanishi K, Yoshikawa N, Matsuo M.
    Pediatr Int; 2006 Apr; 48(2):152-7. PubMed ID: 16635174
    [Abstract] [Full Text] [Related]

  • 9. Mizoribine pulse therapy for a pediatric patient with steroid-resistant nephrotic syndrome.
    Tanaka H, Tsugawa K, Nakahata T, Kudo M, Onuma S, Kimura S, Ito E.
    Tohoku J Exp Med; 2005 Jan; 205(1):87-91. PubMed ID: 15635277
    [Abstract] [Full Text] [Related]

  • 10. Assessment of factors associated with mizoribine responsiveness in children with steroid-dependent nephrotic syndrome.
    Kondoh T, Ikezumi Y, Yokoi K, Nakajima Y, Matsumoto Y, Kaneko M, Hasegawa H, Yamada T, Kumagai N, Ito T, Yoshikawa T.
    Clin Exp Nephrol; 2019 Sep; 23(9):1154-1160. PubMed ID: 31187341
    [Abstract] [Full Text] [Related]

  • 11. The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy.
    Goumenos DS, Kalliakmani P, Tsakas S, Sotsiou F, Vlachojannis JG.
    Clin Nephrol; 2004 Jan; 61(1):17-24. PubMed ID: 14964453
    [Abstract] [Full Text] [Related]

  • 12. Usefulness of mizoribine administration in children with frequently relapsing nephrotic syndrome, and the relationship between pharmacokinetic parameters and efficacy: a multicenter prospective cohort study in China.
    Xia ZK, Gao YF, Rong LP, Dang XQ, Shen Q, Jiang XY, Yi ZW, Xu H.
    World J Pediatr; 2019 Jun; 15(3):262-269. PubMed ID: 30864060
    [Abstract] [Full Text] [Related]

  • 13. Mizoribine for the treatment of lupus nephritis in children and adolescents.
    Tanaka H, Tsugawa K, Tsuruga K, Suzuki K, Nakahata T, Ito E, Waga S.
    Clin Nephrol; 2004 Dec; 62(6):412-7. PubMed ID: 15630899
    [Abstract] [Full Text] [Related]

  • 14. Oral mizoribine pulse therapy for patients with steroid-resistant and frequently relapsing steroid-dependent nephrotic syndrome.
    Kawasaki Y, Hosoya M, Kobayashi S, Ohara S, Onishi N, Takahashi A, Isome M, Suzuki H.
    Nephrol Dial Transplant; 2005 Oct; 20(10):2243-7. PubMed ID: 16030039
    [Abstract] [Full Text] [Related]

  • 15. Effect of single-dose oral mizoribine pulse therapy twice per week for frequently relapsing steroid-dependent nephrotic syndrome.
    Fujieda M, Ishihara M, Morita T, Hayashi A, Okada S, Ohta T, Sakano T, Wakiguchi H.
    Clin Nephrol; 2012 Jul; 78(1):40-6. PubMed ID: 22732336
    [Abstract] [Full Text] [Related]

  • 16. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
    Liang Q, Li H, Xie X, Qu F, Li X, Chen J.
    Ren Fail; 2017 Nov; 39(1):512-518. PubMed ID: 28562168
    [Abstract] [Full Text] [Related]

  • 17. Effect of mizoribine pulse therapy in adult membranous nephropathy.
    Wang X, Zhang M, Zhang W, Liu Y, Han Y, Chang W.
    Int Urol Nephrol; 2021 Apr; 53(4):725-731. PubMed ID: 33159256
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic study of mizoribine in child-onset glomerulonephritis.
    Abe Y, Mikawa T, Fuke T, Hisano M, Tsuji Y, Watanabe S, Itabashi K.
    Pediatr Int; 2008 Oct; 50(5):615-9. PubMed ID: 19261105
    [Abstract] [Full Text] [Related]

  • 19. Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).
    Hama T, Nakanishi K, Ishikura K, Ito S, Nakamura H, Sako M, Saito-Oba M, Nozu K, Shima Y, Iijima K, Yoshikawa N, Japanese Study Group of Kidney Disease in Children (JSKDC).
    BMC Nephrol; 2018 Sep 10; 19(1):223. PubMed ID: 30200895
    [Abstract] [Full Text] [Related]

  • 20. A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey).
    Shibasaki T, Koyama A, Hishida A, Muso E, Osawa G, Yamabe H, Shiiki H, Makino H, Sato H, Ishikawa I, Maeda K, Tomita K, Arakawa M, Ishida M, Sato M, Nagase M, Kashihara N, Yorioka N, Koike T, Saito T, Harada T, Mitarai T, Sugisaki T, Nagasawa T, Tomino Y, Nojima Y, Kobayashi Y, Sakai O.
    Clin Exp Nephrol; 2004 Jun 10; 8(2):117-26. PubMed ID: 15235928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.